WEBB MICHAEL D 4
4 · EPIX Pharmaceuticals, Inc. · Filed Oct 26, 2004
Insider Transaction Report
Form 4
WEBB MICHAEL D
DirectorChief Executive Officer
Transactions
- Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-22$16.70/sh−700$11,690→ 39,012 total - Exercise/Conversion
Common Stock
2004-10-22$0.45/sh+5,000$2,270→ 43,912 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-22$16.50/sh−2,500$41,250→ 41,412 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-22$16.75/sh−100$1,675→ 38,912 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-22$16.65/sh−1,700$28,305→ 39,712 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-10-22$0.45/sh+5,000$2,270Exercise: $0.45From: 1999-12-16Exp: 2004-12-16→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]Reporting person indirectly owns 2,500 shares of common stock through his spouse.
- [F2]From December 16, 1994 grant of 330,467 options to purchase shares of common stock of which 302,326 options have been exercised and the remaining 32,461 options are currently exercisable.